Partial Opioid Agonist [EPC]

Partial Opioid Agonist [EPC] was reported 93918 times

These side effects are most commonly reported by patients taking drugs of the Partial Opioid Agonist [EPC] class:

# Drug class Count
0 DEATH 13443
1 DRUG DEPENDENCE 12578
2 OVERDOSE 11035
3 TOXICITY TO VARIOUS AGENTS 10861
4 PAIN 8379
5 DRUG WITHDRAWAL SYNDROME 7139
6 DRUG INEFFECTIVE 6528
7 EMOTIONAL DISTRESS 5459
8 NAUSEA 4712
9 DRUG ABUSE 3891
10 PRODUCT ADHESION ISSUE 3452
11 APPLICATION SITE RASH 3071
12 INADEQUATE ANALGESIA 3056
13 DIZZINESS 2822
14 RASH 2626
15 VOMITING 2549
16 HEADACHE 2482
17 APPLICATION SITE PRURITUS 2388
18 OFF LABEL USE 2311
19 FATIGUE 2075
20 DEPRESSION 1866
21 MATERNAL EXPOSURE DURING PREGNANCY 1855
22 ANXIETY 1830
23 DYSPNOEA 1830
24 DRUG WITHDRAWAL SYNDROME NEONATAL 1797
25 APPLICATION SITE ERYTHEMA 1777
26 SOMNOLENCE 1746
27 APPLICATION SITE IRRITATION 1713
28 DRUG EFFECT DECREASED 1691
29 CONFUSIONAL STATE 1661
30 DIARRHOEA 1625
31 MALAISE 1568
32 ASTHENIA 1537
33 INSOMNIA 1498
34 ARTHRALGIA 1470
35 FOETAL EXPOSURE DURING PREGNANCY 1347
36 ABDOMINAL PAIN UPPER 1339
37 HYPERHIDROSIS 1314
38 FALL 1313
39 DRUG INTOLERANCE 1293
40 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1259
41 CONDITION AGGRAVATED 1240
42 PRURITUS 1221
43 HYPOAESTHESIA 1164
44 GENERAL PHYSICAL HEALTH DETERIORATION 1137
45 INTENTIONAL PRODUCT USE ISSUE 1072
46 FEELING ABNORMAL 1071
47 PARAESTHESIA 1060
48 ABDOMINAL DISCOMFORT 1050
49 HYPERTENSION 1032
50 APPLICATION SITE VESICLES 1026
51 INJECTION SITE PAIN 1026
52 WITHDRAWAL SYNDROME 1026
53 DRUG HYPERSENSITIVITY 1021
54 PNEUMONIA 1011
55 MEMORY IMPAIRMENT 994
56 CONSTIPATION 984
57 DRUG INTERACTION 979
58 GASTROOESOPHAGEAL REFLUX DISEASE 978
59 INTENTIONAL PRODUCT MISUSE 964
60 BLISTER 949
61 MUSCLE SPASMS 948
62 EPILEPSY 947
63 APPLICATION SITE PAIN 944
64 MIGRAINE 938
65 DRY MOUTH 936
66 PRODUCT USE IN UNAPPROVED INDICATION 930
67 ACCIDENTAL OVERDOSE 919
68 PRODUCT QUALITY ISSUE 909
69 RHEUMATOID ARTHRITIS 900
70 PAIN IN EXTREMITY 898
71 URTICARIA 895
72 APPLICATION SITE REACTION 885
73 ALOPECIA 880
74 PERIPHERAL SWELLING 879
75 DECREASED APPETITE 875
76 EXPOSURE DURING PREGNANCY 872
77 WEIGHT INCREASED 871
78 SYSTEMIC LUPUS ERYTHEMATOSUS 858
79 PSORIATIC ARTHROPATHY 857
80 SWELLING 850
81 ARTHROPATHY 845
82 BLEPHAROSPASM 844
83 INJURY 843
84 PEMPHIGUS 825
85 TYPE 2 DIABETES MELLITUS 819
86 INFUSION RELATED REACTION 811
87 JOINT SWELLING 811
88 INFLAMMATION 798
89 PRODUCT USE ISSUE 794
90 WOUND 794
91 PERICARDITIS 792
92 SYNOVITIS 792
93 GLOSSODYNIA 790
94 BURSITIS 788
95 NASOPHARYNGITIS 788
96 DUODENAL ULCER PERFORATION 785
97 FIBROMYALGIA 785
98 BREAST CANCER STAGE III 782
99 C-REACTIVE PROTEIN INCREASED 771
100 HAND DEFORMITY 768
101 SLEEP DISORDER 766
102 HEPATIC ENZYME INCREASED 760
103 STOMATITIS 759
104 TASTE DISORDER 759
105 ABDOMINAL PAIN 753
106 FOLLICULITIS 748
107 WHEEZING 744
108 HELICOBACTER INFECTION 743
109 MUSCULAR WEAKNESS 743
110 FACET JOINT SYNDROME 733
111 LOWER RESPIRATORY TRACT INFECTION 731
112 BLOOD CHOLESTEROL INCREASED 721
113 CONTRAINDICATED PRODUCT ADMINISTERED 717
114 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 710
115 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 700
116 APPLICATION SITE BURN 700
117 HYPERSENSITIVITY 693
118 LIVER INJURY 690
119 MOBILITY DECREASED 689
120 OSTEOARTHRITIS 689
121 THERAPEUTIC PRODUCT EFFECT DECREASED 688
122 IMPAIRED HEALING 671
123 WOUND INFECTION 665
124 PYREXIA 663
125 LUNG DISORDER 655
126 NECK PAIN 649
127 MUSCLE INJURY 646
128 IRRITABLE BOWEL SYNDROME 643
129 DYSPEPSIA 638
130 GAIT INABILITY 637
131 INJECTION SITE REACTION 633
132 HYPERCHOLESTEROLAEMIA 632
133 LIP DRY 628
134 NIGHT SWEATS 624
135 BACK INJURY 618
136 GASTROINTESTINAL DISORDER 613
137 OBESITY 612
138 NAIL DISORDER 611
139 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 607
140 JOINT RANGE OF MOTION DECREASED 602
141 MUSCULOSKELETAL PAIN 595
142 TREATMENT FAILURE 595
143 PERIPHERAL VENOUS DISEASE 590
144 WEIGHT DECREASED 586
145 SKIN IRRITATION 585
146 NO ADVERSE EVENT 574
147 UNEVALUABLE EVENT 574
148 ONYCHOMADESIS 567
149 MUSCULOSKELETAL STIFFNESS 565
150 LIVE BIRTH 560
151 ABDOMINAL DISTENSION 556
152 MENTAL DISORDER 553
153 RHEUMATIC FEVER 552
154 TACHYCARDIA 548
155 HALLUCINATION 522
156 BACK PAIN 520
157 DRUG-INDUCED LIVER INJURY 519
158 SUICIDAL IDEATION 517
159 TREMOR 514
160 COMA 511
161 SUBSTANCE ABUSE 508
162 CHEST PAIN 503
163 ILL-DEFINED DISORDER 502
164 OEDEMA PERIPHERAL 499
165 LOSS OF CONSCIOUSNESS 490
166 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 489
167 EXTRA DOSE ADMINISTERED 487
168 LIVER FUNCTION TEST INCREASED 487
169 CHILLS 486
170 GRIP STRENGTH DECREASED 483
171 LEARNING DISABILITY 468
172 WRONG TECHNIQUE IN DRUG USAGE PROCESS 461
173 MYALGIA 457
174 DRUG EFFECT INCREASED 453
175 BLOOD PRESSURE INCREASED 435
176 DRUG USE DISORDER 430
177 GAIT DISTURBANCE 429
178 HYPOTENSION 429
179 COUGH 426
180 AMNESIA 424
181 HEPATITIS 421
182 ONYCHOMYCOSIS 421
183 ORAL ADMINISTRATION COMPLICATION 421
184 PRODUCT SOLUBILITY ABNORMAL 419
185 THERAPEUTIC RESPONSE DECREASED 418
186 COELIAC DISEASE 417
187 SYNCOPE 417
188 C-REACTIVE PROTEIN ABNORMAL 410
189 HOSPITALISATION 410
190 AGITATION 406
191 DRUG ADMINISTERED AT INAPPROPRIATE SITE 404
192 SEDATION 404
193 DISABILITY 403
194 APPLICATION SITE DISCOLOURATION 402
195 CARDIO-RESPIRATORY ARREST 390
196 DEVELOPMENTAL DELAY 386
197 SEIZURE 385
198 INJECTION SITE ERYTHEMA 384
199 ROAD TRAFFIC ACCIDENT 370
200 SEPSIS 370
201 EUPHORIC MOOD 365
202 CONGENITAL ANOMALY 364
203 RESPIRATORY DEPRESSION 363
204 FINGER DEFORMITY 360
205 DISCOMFORT 359
206 CARDIAC DISORDER 358
207 DRUG DIVERSION 355
208 PALPITATIONS 350
209 VISION BLURRED 349
210 ACUTE KIDNEY INJURY 343
211 ADVERSE REACTION 340
212 PRODUCT LABEL CONFUSION 336
213 CONTUSION 326
214 ILLNESS 323
215 INFECTION 321
216 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 320
217 DELIRIUM 311
218 PRODUCT DOSE OMISSION ISSUE 310
219 TINNITUS 310
220 AGGRESSION 309
221 ERYTHEMA 303
222 SUBSTANCE USE DISORDER 303
223 ALTERED STATE OF CONSCIOUSNESS 301
224 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 297
225 MIOSIS 297
226 SUICIDE ATTEMPT 295
227 SKIN REACTION 293
228 ADVERSE DRUG REACTION 292
229 HAEMATEMESIS 292
230 LETHARGY 292
231 ADVERSE EVENT 290
232 BREAKTHROUGH PAIN 290
233 COMPLETED SUICIDE 285
234 BLINDNESS 282
235 ASTHMA 281
236 PRODUCT SUBSTITUTION ISSUE 280
237 DISTURBANCE IN ATTENTION 276
238 DEPENDENCE 274
239 THERAPEUTIC RESPONSE SHORTENED 265
240 DYSARTHRIA 256
241 DRUG SCREEN POSITIVE 252
242 UNDERDOSE 249
243 HEPATITIS C 247
244 URINARY TRACT INFECTION 247
245 PULMONARY OEDEMA 246
246 RHABDOMYOLYSIS 243
247 DISORIENTATION 242
248 DIPLOPIA 241
249 OEDEMA 241
250 PRESYNCOPE 239
251 PRODUCT PHYSICAL ISSUE 239
252 DEPRESSED LEVEL OF CONSCIOUSNESS 238
253 DRUG SCREEN NEGATIVE 237
254 INFUSION SITE REACTION 236
255 TOOTH LOSS 235
256 COGNITIVE DISORDER 233
257 DENTAL CARIES 232
258 RESTLESSNESS 232
259 HAEMATURIA 231
260 EYE PAIN 230
261 HEAD DISCOMFORT 226
262 CARDIAC ARREST 221
263 GENERALISED OEDEMA 221
264 HAEMORRHAGIC STROKE 221
265 INCORRECT DOSE ADMINISTERED 214
266 ASCITES 212
267 DRUG TOLERANCE 210
268 HEART RATE INCREASED 210
269 BALANCE DISORDER 208
270 PHOTOPHOBIA 208
271 APPLICATION SITE URTICARIA 205
272 IRRITABILITY 205
273 MENTAL IMPAIRMENT 204
274 APPLICATION SITE SCAR 200
275 OCULAR DISCOMFORT 198
276 PRESCRIBED OVERDOSE 197
277 APPLICATION SITE EXFOLIATION 195
278 DYSPHAGIA 195
279 URINARY TRACT DISORDER 195
280 AMAUROSIS FUGAX 193
281 PRODUCT PHYSICAL CONSISTENCY ISSUE 192
282 BURNING SENSATION 191
283 PRODUCT PACKAGING QUANTITY ISSUE 191
284 SINUSITIS 191
285 INTENTIONAL OVERDOSE 190
286 ABNORMAL BEHAVIOUR 189
287 ANAEMIA 189
288 APPLICATION SITE DISCHARGE 188
289 DEHYDRATION 187
290 DERMATITIS CONTACT 187
291 FEELING HOT 186
292 APPLICATION SITE EROSION 184
293 VISUAL IMPAIRMENT 184
294 INJECTION SITE SWELLING 183
295 HOT FLUSH 181
296 UNRESPONSIVE TO STIMULI 180
297 PREMATURE BABY 179
298 DEVICE LEAKAGE 177
299 URINARY RETENTION 176
300 INFLUENZA LIKE ILLNESS 175
301 NEUROPATHY PERIPHERAL 174
302 SEROTONIN SYNDROME 173
303 CHEST DISCOMFORT 172
304 ASPHYXIA 171
305 AUTOIMMUNE DISORDER 171
306 MEDICATION ERROR 170
307 INJECTION SITE INFECTION 168
308 INJECTION SITE PRURITUS 168
309 CEREBROVASCULAR ACCIDENT 164
310 POST-TRAUMATIC STRESS DISORDER 164
311 RESPIRATORY ARREST 164
312 BRAIN OEDEMA 159
313 APPLICATION SITE SWELLING 158
314 HYPERAESTHESIA 158
315 LIVER DISORDER 158
316 LOWER LIMB FRACTURE 157
317 INJECTION SITE EXTRAVASATION 156
318 IMPAIRED WORK ABILITY 154
319 RENAL FAILURE 154
320 IMPAIRED DRIVING ABILITY 151
321 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 149
322 MYOCARDIAL INFARCTION 147
323 OXYGEN SATURATION DECREASED 147
324 VERTIGO 144
325 ANGER 143
326 ARTHRITIS 143
327 NORMAL NEWBORN 142
328 PNEUMONIA ASPIRATION 142
329 RESPIRATORY DISORDER 142
330 SCIATICA 142
331 SWELLING FACE 142
332 DEPRESSED MOOD 139
333 INJECTION SITE BRUISING 139
334 PARANOIA 139
335 DRUG DETOXIFICATION 138
336 POISONING 137
337 THERAPY NON-RESPONDER 137
338 RESTLESS LEGS SYNDROME 136
339 RHINORRHOEA 136
340 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 135
341 SWOLLEN JOINT COUNT INCREASED 134
342 EAR PAIN 133
343 PREMATURE DELIVERY 132
344 PSYCHOTIC DISORDER 132
345 SURGERY 132
346 NERVOUSNESS 130
347 TOOTHACHE 130
348 PRURITUS GENERALISED 129
349 APPLICATION SITE DRYNESS 128
350 BREAST CANCER STAGE II 127
351 HEPATIC CIRRHOSIS 127
352 PANIC ATTACK 127
353 STRESS 127
354 INCORRECT PRODUCT ADMINISTRATION DURATION 125
355 LARYNGITIS 125
356 ATRIAL FIBRILLATION 123
357 DYSURIA 123
358 RHEUMATOID FACTOR POSITIVE 123
359 COVID-19 121
360 OSTEOPOROSIS 121
361 PSORIASIS 121
362 BONE EROSION 120
363 DERMATITIS ALLERGIC 119
364 EXOSTOSIS 119
365 HYPERSOMNIA 119
366 NIGHTMARE 119
367 OROPHARYNGEAL PAIN 119
368 PULMONARY EMBOLISM 119
369 RENAL IMPAIRMENT 119
370 JOINT STIFFNESS 118
371 ORAL DISCOMFORT 118
372 PULMONARY FIBROSIS 117
373 RESPIRATORY FAILURE 116
374 DEEP VEIN THROMBOSIS POSTOPERATIVE 115
375 PRESCRIBED UNDERDOSE 115
376 PRODUCT ADMINISTRATION ERROR 115
377 RED BLOOD CELL SEDIMENTATION RATE INCREASED 115
378 PRODUCT PRESCRIBING ERROR 114
379 EXPOSURE VIA BREAST MILK 113
380 TREATMENT NONCOMPLIANCE 113
381 BRADYCARDIA 112
382 DISLOCATION OF VERTEBRA 112
383 INFLUENZA 112
384 INJECTION SITE INDURATION 112
385 CELLULITIS 111
386 CROHN^S DISEASE 111
387 QUALITY OF LIFE DECREASED 110
388 ELECTROCARDIOGRAM QT PROLONGED 108
389 LIP SWELLING 108
390 MOOD SWINGS 108
391 CARDIAC FAILURE 107
392 RESPIRATORY DISTRESS 107
393 DRUG DELIVERY SYSTEM REMOVAL 106
394 HYPONATRAEMIA 106
395 PRODUCT PRESCRIBING ISSUE 106
396 SKIN BURNING SENSATION 106
397 INJECTION SITE MASS 105
398 TOOTH DISORDER 105
399 TOOTH FRACTURE 105
400 COLD SWEAT 103
401 HALLUCINATION, VISUAL 103
402 HYPOKALAEMIA 103
403 INJECTION SITE NECROSIS 103
404 BRONCHITIS 102
405 DEMENTIA 102
406 HYPOGLYCAEMIA 102
407 HYPOXIA 102
408 CHRONIC KIDNEY DISEASE 101
409 IMPAIRED QUALITY OF LIFE 101
410 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 100
411 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 100
412 INJECTION SITE ABSCESS 99
413 RASH GENERALISED 99
414 X-RAY ABNORMAL 99
415 ULCER HAEMORRHAGE 98
416 APPLICATION SITE SCAB 97
417 BONE PAIN 97
418 FLUSHING 97
419 DYSGEUSIA 96
420 THROMBOCYTOPENIA 96
421 CRYING 95
422 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 94
423 THERMAL BURN 94
424 DYSKINESIA 93
425 PANCREATITIS 93
426 POISONING DELIBERATE 92
427 ALCOHOL ABUSE 91
428 BRAIN INJURY 91
429 TOOTH EROSION 91
430 DRUG EFFECT INCOMPLETE 90
431 URINARY INCONTINENCE 90
432 ABORTION SPONTANEOUS 89
433 DRUG LEVEL FLUCTUATING 89
434 INJECTION SITE CELLULITIS 89
435 INJECTION SITE ULCER 89
436 SWOLLEN TONGUE 89
437 MYELOPATHY 88
438 RASH PRURITIC 88
439 APPLICATION SITE HAEMORRHAGE 87
440 BLOOD PRESSURE DECREASED 87
441 CARDIAC FAILURE CONGESTIVE 87
442 DYSPHONIA 87
443 SLEEP APNOEA SYNDROME 87
444 ACCIDENTAL EXPOSURE TO PRODUCT 86
445 FEELING JITTERY 86
446 GASTROINTESTINAL HAEMORRHAGE 86
447 GENERAL PHYSICAL CONDITION ABNORMAL 86
448 ARRHYTHMIA 85
449 ERECTILE DYSFUNCTION 85
450 NEURALGIA 85
451 PRODUCT CONTAMINATION 85
452 UPPER RESPIRATORY TRACT INFECTION 85
453 ACCIDENTAL POISONING 84
454 FLUID RETENTION 84
455 LUPUS-LIKE SYNDROME 84
456 THINKING ABNORMAL 84
457 APPLICATION SITE HYPERSENSITIVITY 83
458 ENCEPHALOPATHY 83
459 MENTAL STATUS CHANGES 83
460 RECTAL HAEMORRHAGE 83
461 SPEECH DISORDER 83
462 MYDRIASIS 82
463 SPINA BIFIDA 82
464 NEUTROPENIA 80
465 PRODUCT DISPENSING ERROR 80
466 PRODUCT TASTE ABNORMAL 80
467 THERAPEUTIC RESPONSE UNEXPECTED 80
468 DELUSION 79
469 DRUG EFFECT LESS THAN EXPECTED 79
470 MUSCLE TWITCHING 79
471 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 79
472 FEELING COLD 78
473 BEDRIDDEN 77
474 PULMONARY CONGESTION 77
475 YAWNING 77
476 BRADYPNOEA 76
477 HIP ARTHROPLASTY 76
478 LUPUS VULGARIS 76
479 SKIN EXFOLIATION 76
480 ASPIRATION 75
481 THERAPY CESSATION 75
482 HEPATIC ENZYME 74
483 DEEP VEIN THROMBOSIS 73
484 EPISTAXIS 73
485 FREQUENT BOWEL MOVEMENTS 73
486 LACRIMATION INCREASED 72
487 LEUKOPENIA 71
488 LOW BIRTH WEIGHT BABY 71
489 NERVOUS SYSTEM DISORDER 71
490 OVERLAP SYNDROME 71
491 APPLICATION SITE DERMATITIS 70
492 DYSSTASIA 70
493 EMOTIONAL DISORDER 70
494 HAEMORRHAGE 70
495 HALLUCINATION, AUDITORY 70
496 MOOD ALTERED 70
497 BIPOLAR DISORDER 69
498 INJECTION SITE IRRITATION 69
499 INJECTION SITE WARMTH 69
500 KNEE ARTHROPLASTY 69
501 WHITE BLOOD CELL COUNT INCREASED 69
502 DRY SKIN 68
503 HEAD INJURY 68
504 METABOLIC ACIDOSIS 67
505 INTENTIONAL SELF-INJURY 66
506 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 66
507 THROMBOSIS 66
508 EAR INFECTION 65
509 POLLAKIURIA 65
510 POOR FEEDING INFANT 65
511 POOR QUALITY SLEEP 65
512 CYANOSIS 64
513 INTESTINAL OBSTRUCTION 64
514 PRODUCT COLOUR ISSUE 64
515 STAPHYLOCOCCAL INFECTION 64
516 BLOOD CREATINE PHOSPHOKINASE INCREASED 63
517 FEELING OF BODY TEMPERATURE CHANGE 63
518 INJECTION SITE RASH 63
519 MALIGNANT NEOPLASM PROGRESSION 63
520 MOVEMENT DISORDER 63
521 PREGNANCY 63
522 RENAL DISORDER 63
523 NEPHROLITHIASIS 62
524 PRODUCT STORAGE ERROR 62
525 HEART RATE DECREASED 61
526 INJECTION SITE DISCHARGE 61
527 PLEURAL EFFUSION 61
528 PRODUCT USE COMPLAINT 61
529 SKIN DISORDER 61
530 SMALL FOR DATES BABY 61
531 AFFECTIVE DISORDER 60
532 APATHY 60
533 BEHAVIOUR DISORDER 60
534 CONVULSION 60
535 DRUG LEVEL INCREASED 60
536 INJECTION SITE EROSION 60
537 LIBIDO DECREASED 60
538 MUSCLE RIGIDITY 60
539 APHASIA 59
540 HAEMOGLOBIN DECREASED 59
541 LIMB INJURY 59
542 MYOCLONUS 59
543 SCAR 59
544 SEPTIC SHOCK 59
545 ANAPHYLACTIC REACTION 58
546 BLOOD GLUCOSE INCREASED 58
547 DRY EYE 58
548 QUADRIPARESIS 58
549 RIB FRACTURE 58
550 THERAPY INTERRUPTED 58
551 BACK DISORDER 57
552 CHROMATURIA 57
553 FEAR 57
554 INJECTION SITE HAEMORRHAGE 57
555 NEOPLASM MALIGNANT 57
556 PERSONALITY CHANGE 57
557 SELF ESTEEM DECREASED 57
558 SKIN LESION 57
559 SPINAL OPERATION 57
560 WALKING AID USER 57
561 BLOOD PRESSURE FLUCTUATION 56
562 C-REACTIVE PROTEIN 56
563 INTENTIONAL DOSE OMISSION 56
564 INTENTIONAL DRUG MISUSE 56
565 MAJOR DEPRESSION 56
566 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56
567 SENSORY DISTURBANCE 56
568 LOCAL SWELLING 55
569 LOGORRHOEA 55
570 PRODUCT DOSE OMISSION 55
571 APPLICATION SITE INFLAMMATION 54
572 COMPARTMENT SYNDROME 54
573 DISEASE PROGRESSION 54
574 FEELING DRUNK 54
575 FLATULENCE 54
576 GASTRIC ULCER 54
577 HAEMATOCHEZIA 54
578 INCOHERENT 54
579 LIVER FUNCTION TEST ABNORMAL 54
580 MEDICATION RESIDUE PRESENT 54
581 ORTHOSTATIC HYPOTENSION 54
582 RASH ERYTHEMATOUS 54
583 RASH VESICULAR 54
584 SCHIZOPHRENIA 54
585 BODY TEMPERATURE DECREASED 53
586 COLITIS ULCERATIVE 53
587 HEART RATE IRREGULAR 53
588 INTENTIONAL UNDERDOSE 53
589 UPPER GASTROINTESTINAL HAEMORRHAGE 53
590 ABNORMAL DREAMS 52
591 ACCIDENT 52
592 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 52
593 CARDIOMEGALY 52
594 DIABETES MELLITUS 52
595 ENDOCARDITIS 52
596 HYPOTHYROIDISM 52
597 PORPHYRIA ACUTE 52
598 RESPIRATORY TRACT INFECTION 52
599 STRESS CARDIOMYOPATHY 52
600 BRAIN FOG 51
601 FOOT FRACTURE 51
602 OCULAR HYPERAEMIA 51
603 SOMNAMBULISM 51
604 DEVICE MALFUNCTION 50
605 HYPOCHOLESTEROLAEMIA 50
606 INJECTION SITE INFLAMMATION 50
607 LIMB DISCOMFORT 50
608 MATERNAL EXPOSURE TIMING UNSPECIFIED 50
609 NASAL CONGESTION 50
610 PALLOR 50
611 SKIN DISCOLOURATION 50
612 FOETAL GROWTH RESTRICTION 49
613 PRODUCT AVAILABILITY ISSUE 49
614 ACUTE RESPIRATORY DISTRESS SYNDROME 48
615 APPLICATION SITE BRUISE 48
616 IMPAIRED GASTRIC EMPTYING 48
617 LABORATORY TEST ABNORMAL 48
618 NERVE INJURY 48
619 PANCYTOPENIA 48
620 PROCEDURAL PAIN 48
621 PRODUCT PACKAGING ISSUE 48
622 SUBSTANCE USE 48
623 THROAT TIGHTNESS 48
624 APPLICATION SITE ULCER 47
625 BLOOD CREATININE INCREASED 47
626 JOINT INJURY 47
627 LOCALISED INFECTION 47
628 PRODUCT ADMINISTRATION INTERRUPTED 47
629 SNEEZING 47
630 DRUG PRESCRIBING ERROR 46
631 INTERVERTEBRAL DISC PROTRUSION 46
632 JOINT DISLOCATION 46
633 PLACENTAL DISORDER 46
634 RETINITIS 46
635 SKIN ULCER 46
636 TONGUE DISCOMFORT 46
637 APPLICATION SITE PERSPIRATION 45
638 COORDINATION ABNORMAL 45
639 JAUNDICE NEONATAL 45
640 MOUTH ULCERATION 45
641 ORAL MUCOSAL BLISTERING 45
642 PRODUCT SIZE ISSUE 45
643 RENAL FAILURE ACUTE 45
644 SEXUAL DYSFUNCTION 45
645 APPLICATION SITE PAPULES 44
646 NEUROLEPTIC MALIGNANT SYNDROME 44
647 PRODUCT DISPENSING ISSUE 44
648 SPINAL PAIN 44
649 TOOTH INJURY 44
650 ANGIOEDEMA 43
651 ECZEMA 43
652 HEPATIC FUNCTION ABNORMAL 43
653 HYPOPNOEA 43
654 PLATELET COUNT DECREASED 43
655 PSYCHOMOTOR HYPERACTIVITY 43
656 SOPOR 43
657 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 43
658 APPLICATION SITE DISCOMFORT 42
659 DRUG DOSE OMISSION 42
660 FEEDING DISORDER 42
661 GENERALISED TONIC-CLONIC SEIZURE 42
662 INJECTION SITE VESICLES 42
663 MANIA 42
664 ANGINA PECTORIS 41
665 BRADYKINESIA 41
666 DYSPNOEA EXERTIONAL 41
667 DYSTONIA 41
668 EATING DISORDER 41
669 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 41
670 PRODUCT DOSE OMISSION IN ERROR 41
671 SPINAL FRACTURE 41
672 WHITE BLOOD CELL COUNT DECREASED 41
673 ALANINE AMINOTRANSFERASE INCREASED 40
674 APPLICATION SITE WARMTH 40
675 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40
676 DEVICE ADHESION ISSUE 40
677 DYSPHORIA 40
678 EXTRAPYRAMIDAL DISORDER 40
679 HEPATIC FAILURE 40
680 MALNUTRITION 40
681 OSTEOMYELITIS 40
682 PRODUCT FORMULATION ISSUE 40
683 PRODUCTIVE COUGH 40
684 CHOLELITHIASIS 39
685 EXPOSURE DURING BREAST FEEDING 39
686 HYPERKALAEMIA 39
687 HYPOTHERMIA 39
688 IMMUNE SYSTEM DISORDER 39
689 MYOSITIS 39
690 ORAL PAIN 39
691 PHARYNGITIS STREPTOCOCCAL 39
692 PRE-EXISTING CONDITION IMPROVED 39
693 PRODUCT ODOUR ABNORMAL 39
694 PUSTULAR PSORIASIS 39
695 RETCHING 39
696 THERAPEUTIC RESPONSE DELAYED 39
697 TORSADE DE POINTES 39
698 APNOEA 38
699 APPLICATION SITE ODOUR 38
700 GASTRIC DISORDER 38
701 HERPES ZOSTER 38
702 HIP FRACTURE 38
703 PNEUMONITIS 38
704 SUDDEN DEATH 38
705 ACUTE MYOCARDIAL INFARCTION 37
706 ALCOHOL INTERACTION 37
707 BLOOD PRESSURE SYSTOLIC INCREASED 37
708 CEREBRAL HAEMORRHAGE 37
709 CIRCULATORY COLLAPSE 37
710 DEVICE ISSUE 37
711 DRUG ADMINISTRATION ERROR 37
712 DRUG LEVEL DECREASED 37
713 GOUT 37
714 HYPOKINESIA 37
715 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 37
716 MULTIPLE CONGENITAL ABNORMALITIES 37
717 PERSECUTORY DELUSION 37
718 TOXIC ENCEPHALOPATHY 37
719 ACUTE RESPIRATORY FAILURE 36
720 FEMUR FRACTURE 36
721 FORMICATION 36
722 HYPOAESTHESIA ORAL 36
723 HYPOPHAGIA 36
724 INTERVERTEBRAL DISC DEGENERATION 36
725 MULTIPLE SCLEROSIS 36
726 MUSCLE SPASTICITY 36
727 TACHYPNOEA 36
728 TOOTH EXTRACTION 36
729 BRADYPHRENIA 35
730 CAESAREAN SECTION 35
731 CARPAL TUNNEL SYNDROME 35
732 CATARACT 35
733 HOMICIDE 35
734 HYPERTHERMIA 35
735 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35
736 MOUTH SWELLING 35
737 SINUS TACHYCARDIA 35
738 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35
739 THROAT IRRITATION 35
740 ACCIDENTAL DEATH 34
741 ACTIVITIES OF DAILY LIVING IMPAIRED 34
742 ANHEDONIA 34
743 ECONOMIC PROBLEM 34
744 EYE SWELLING 34
745 HYPOCALCAEMIA 34
746 INCORRECT ROUTE OF DRUG ADMINISTRATION 34
747 JAUNDICE 34
748 KIDNEY INFECTION 34
749 MULTIPLE SCLEROSIS RELAPSE 34
750 MUSCLE ATROPHY 34
751 NEONATAL RESPIRATORY DISTRESS 34
752 PAIN IN JAW 34
753 PELVIC PAIN 34
754 PSYCHOMOTOR SKILLS IMPAIRED 34
755 RHESUS INCOMPATIBILITY 34
756 SPUTUM DISCOLOURED 34
757 CHOKING 33
758 CLUMSINESS 33
759 DEAFNESS NEUROSENSORY 33
760 DERMATITIS 33
761 FAECES DISCOLOURED 33
762 FOETAL DISTRESS SYNDROME 33
763 FOOT DEFORMITY 33
764 GASTRITIS 33
765 HYPERCAPNIA 33
766 HYPERGLYCAEMIA 33
767 INJECTION SITE DISCOLOURATION 33
768 MONOPLEGIA 33
769 PRODUCT COMPLAINT 33
770 SPINAL OSTEOARTHRITIS 33
771 SPINAL STENOSIS 33
772 TARDIVE DYSKINESIA 33
773 ABNORMAL LOSS OF WEIGHT 32
774 ANKYLOSING SPONDYLITIS 32
775 BODY TEMPERATURE INCREASED 32
776 IMPRISONMENT 32
777 INJECTION SITE NODULE 32
778 MATERNAL DRUGS AFFECTING FOETUS 32
779 MELAENA 32
780 OSTEOPENIA 32
781 PAIN OF SKIN 32
782 PARAESTHESIA ORAL 32
783 RASH MACULAR 32
784 RESPIRATORY RATE DECREASED 32
785 TRANSIENT ISCHAEMIC ATTACK 32
786 UROSEPSIS 32
787 VISCERAL CONGESTION 32
788 DRUG TOLERANCE DECREASED 31
789 FAECALOMA 31
790 FUNGAL INFECTION 31
791 HAEMATOMA 31
792 LOSS OF LIBIDO 31
793 POLYNEUROPATHY 31
794 POTENTIATING DRUG INTERACTION 31
795 SOCIAL AVOIDANT BEHAVIOUR 31
796 SPINAL FUSION SURGERY 31
797 THERAPEUTIC RESPONSE INCREASED 31
798 ABSCESS 30
799 ACNE 30
800 ALCOHOLISM 30
801 ANKLE FRACTURE 30
802 BLOOD PRESSURE DIASTOLIC DECREASED 30
803 CARDIOMYOPATHY 30
804 COLITIS 30
805 DIZZINESS POSTURAL 30
806 FACIAL PAIN 30
807 FOETAL DEATH 30
808 HEART RATE ABNORMAL 30
809 INSURANCE ISSUE 30
810 INTERNATIONAL NORMALISED RATIO INCREASED 30
811 METASTASES TO BONE 30
812 OVERWEIGHT 30
813 SCAB 30
814 SCREAMING 30
815 ALCOHOL POISONING 29
816 APPLICATION SITE PUSTULES 29
817 COMMUNICATION DISORDER 29
818 FEBRILE NEUTROPENIA 29
819 GUN SHOT WOUND 29
820 HYPERTONIA 29
821 HYPOTONIA 29
822 INJECTION SITE DISCOMFORT 29
823 PRODUCT COMMUNICATION ISSUE 29
824 PRODUCT PACKAGING DIFFICULT TO OPEN 29
825 SALIVARY HYPERSECRETION 29
826 SKIN ABRASION 29
827 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 29
828 ANXIETY DISORDER 28
829 APPLICATION SITE INFECTION 28
830 ATAXIA 28
831 BLOOD PRESSURE DIASTOLIC ABNORMAL 28
832 BREECH PRESENTATION 28
833 EXPULSION OF MEDICATION 28
834 FAECES SOFT 28
835 GENERAL SYMPTOM 28
836 HYPOACUSIS 28
837 INJECTION SITE URTICARIA 28
838 LEUKOCYTOSIS 28
839 NEURODEGENERATIVE DISORDER 28
840 PERIPHERAL COLDNESS 28
841 PHARYNGEAL OEDEMA 28
842 SINUS CONGESTION 28
843 SKIN INFECTION 28
844 TENDERNESS 28
845 TOOTH ABSCESS 28
846 TRANSAMINASES INCREASED 28
847 APPLICATION SITE PARAESTHESIA 27
848 BLOOD TESTOSTERONE DECREASED 27
849 CYSTITIS 27
850 DIVERTICULITIS 27
851 GINGIVAL PAIN 27
852 HAEMORRHOIDS 27
853 LYMPHADENOPATHY 27
854 NEUROTOXICITY 27
855 PANIC REACTION 27
856 PARALYSIS 27
857 POOR QUALITY PRODUCT ADMINISTERED 27
858 SKIN LACERATION 27
859 SUBSTANCE DEPENDENCE 27
860 SWOLLEN JOINT COUNT 27
861 TOOTH INFECTION 27
862 VICTIM OF CRIME 27
863 WEIGHT FLUCTUATION 27
864 ADRENAL INSUFFICIENCY 26
865 AGEUSIA 26
866 BRUXISM 26
867 CACHEXIA 26
868 FRACTURE 26
869 GASTROINTESTINAL MOTILITY DISORDER 26
870 HUNGER 26
871 HYPERVENTILATION 26
872 INCORRECT DRUG ADMINISTRATION DURATION 26
873 MICROCEPHALY 26
874 PILOERECTION 26
875 SCRATCH 26
876 SEDATION COMPLICATION 26
877 ULCER 26
878 VAGINAL HAEMORRHAGE 26
879 ANAPHYLACTIC SHOCK 25
880 CEREBRAL DISORDER 25
881 DECREASED INTEREST 25
882 EYE HAEMORRHAGE 25
883 EYE INJURY 25
884 IMMUNODEFICIENCY 25
885 MICTURITION URGENCY 25
886 OSTEONECROSIS 25
887 PNEUMOTHORAX 25
888 PRE-ECLAMPSIA 25
889 PRODUCT TEMPERATURE EXCURSION ISSUE 25
890 PULMONARY HYPERTENSION 25
891 SINUS DISORDER 25
892 SPONDYLITIS 25
893 TRANSFUSION 25
894 AFFECT LABILITY 24
895 CENTRAL SLEEP APNOEA SYNDROME 24
896 FEELING OF DESPAIR 24
897 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24
898 HAEMOPTYSIS 24
899 HEPATIC FIBROSIS 24
900 INCREASED APPETITE 24
901 ISCHAEMIC STROKE 24
902 MUSCULOSKELETAL DISCOMFORT 24
903 NEEDLE ISSUE 24
904 RENAL INJURY 24
905 SUICIDAL BEHAVIOUR 24
906 SUSPECTED SUICIDE 24
907 TACHYPHRENIA 24
908 THERAPY CHANGE 24
909 UPPER LIMB FRACTURE 24
910 WRIST FRACTURE 24
911 ARTERIOSCLEROSIS 23
912 ARTERIOSCLEROSIS CORONARY ARTERY 23
913 BLOOD GLUCOSE DECREASED 23
914 BLOOD PRESSURE SYSTOLIC DECREASED 23
915 CONJUNCTIVAL HAEMORRHAGE 23
916 DEFAECATION DISORDER 23
917 DISEASE RECURRENCE 23
918 ELECTRIC SHOCK SENSATION 23
919 EXPIRED PRODUCT ADMINISTERED 23
920 FULL BLOOD COUNT ABNORMAL 23
921 INJECTION SITE OEDEMA 23
922 LOSS OF EMPLOYMENT 23
923 NECK INJURY 23
924 NEOPLASM PROGRESSION 23
925 ORAL CANDIDIASIS 23
926 PANIC DISORDER 23
927 PARKINSON^S DISEASE 23
928 PLACENTAL HYPERTROPHY 23
929 PRODUCT PREPARATION ERROR 23
930 RESPIRATORY ACIDOSIS 23
931 SENSITIVE SKIN 23
932 SUSPECTED OFF LABEL USE 23
933 TEMPERATURE INTOLERANCE 23
934 VICTIM OF SEXUAL ABUSE 23
935 VIRAL INFECTION 23
936 ACUTE HEPATIC FAILURE 22
937 CARDIOGENIC SHOCK 22
938 CENTRAL PAIN SYNDROME 22
939 CHOLESTASIS 22
940 CLEFT PALATE 22
941 CRANIOCEREBRAL INJURY 22
942 DRUG EFFECT DELAYED 22
943 ECHOCARDIOGRAM ABNORMAL 22
944 EYE DISORDER 22
945 EYE PRURITUS 22
946 HALLUCINATIONS, MIXED 22
947 HEPATIC CYTOLYSIS 22
948 HOMICIDAL IDEATION 22
949 HYPERREFLEXIA 22
950 INJECTION SITE SCAR 22
951 LABELLED DRUG-DRUG INTERACTION ISSUE 22
952 MUSCLE TIGHTNESS 22
953 NEPHROPATHY 22
954 NEUTROPHIL COUNT DECREASED 22
955 SKIN NECROSIS 22
956 SMALL INTESTINAL OBSTRUCTION 22
957 TONGUE ULCERATION 22
958 ANAL INCONTINENCE 21
959 BLOOD ALBUMIN DECREASED 21
960 BLOOD POTASSIUM INCREASED 21
961 CLUSTER HEADACHE 21
962 COMA SCALE ABNORMAL 21
963 CORONARY ARTERY DISEASE 21
964 DECREASED ACTIVITY 21
965 DROOLING 21
966 DRUG ABUSER 21
967 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 21
968 ELECTROLYTE IMBALANCE 21
969 END STAGE RENAL DISEASE 21
970 ENERGY INCREASED 21
971 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21
972 GALLBLADDER DISORDER 21
973 GINGIVITIS 21
974 HYDRONEPHROSIS 21
975 ILEUS 21
976 IMMUNOSUPPRESSION 21
977 INITIAL INSOMNIA 21
978 JUDGEMENT IMPAIRED 21
979 METASTASES TO LUNG 21
980 MULTIPLE FRACTURES 21
981 MUSCULOSKELETAL CHEST PAIN 21
982 PHOTOSENSITIVITY REACTION 21
983 TUBULOINTERSTITIAL NEPHRITIS 21
984 URINARY HESITATION 21
985 ABASIA 20
986 ABDOMINAL PAIN LOWER 20
987 ATRIAL SEPTAL DEFECT 20
988 BLOOD ALKALINE PHOSPHATASE INCREASED 20
989 BLOOD DISORDER 20
990 BLOOD POTASSIUM DECREASED 20
991 BONE DENSITY ABNORMAL 20
992 COAGULOPATHY 20
993 GASTROENTERITIS VIRAL 20
994 GLOMERULAR FILTRATION RATE DECREASED 20
995 INJECTION SITE HYPERSENSITIVITY 20
996 KNEE OPERATION 20
997 MUSCULOSKELETAL DISORDER 20
998 NEONATAL RESPIRATORY DISTRESS SYNDROME 20
999 ORAL DISORDER 20